Pharmaceutical Business Review
Return to: PBR Home
Search Results:
1-15 of 56655 results
WuXi STA, Antengene sign drug development and manufacturing deal
STA Pharmaceutical (WuXi STA), a subsidiary of WuXi AppTec, and Antengene have entered into a partnership for the CMC development and manufacturing of innovative oncology drugs.
Production & Manufacturing > Manufacturing > News
Kite, Gadeta collaborate to advance gamma delta T cell receptor technology for solid tumors
Kite and Gadeta have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.
Drug Research > Drug Discovery & Development > News
Novartis to pay EUR95m to Galapagos and MorphoSys for skin drug rights
By PBR Staff Writer
Novartis has agreed to make an upfront payment of EUR95m to Galapagos and MorphoSys to in-license IL-17C compound for atopic dermatitis.
Drug Research > Drug Discovery & Development > News
FDA accepts Immunomedics’ BLA and grants priority review for Sacituzumab Govitecan to treat metastatic triple-negative breast cancer
Immunomedics announced that the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for filing and granted priority review for sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer (mTNBC) who previously received at least two prior therapies for metastatic disease.
News
Takeda, Ovid plan to launch three trials of anti-epileptic drug TAK-935/OV935
Takeda Pharmaceutical and Ovid Therapeutics have revealed details of a clinical development program of their anti-epileptic drug TAK-935/OV935 in rare developmental and epileptic encephalopathies (DEE).
Contract Research & Services > Clinical Trials > News
Pfizer, Lilly’s osteoarthritis pain drug meets co-primary endpoints in phase 3 study
By PBR Staff Writer
Pfizer and Eli Lilly’s osteoarthritis (OA) pain drug, tanezumab, has met all three co-primary endpoints in a phase 3 study.
Contract Research & Services > Clinical Trials > News
Drug Delivery System Benefits from Demand for Targeted Drug Delivery for Several Diseases
The global drug delivery system market is poised for significant growth in the years ahead. This is on the back of increasing demand for home healthcare devices and self-administration of drugs to minimize hospital stay.
Press Releases
EUSA Pharma to buy global rights of Janssen’s Sylvant for $115m
By PBR Staff Writer
UK-based EUSA Pharma has agreed to acquire the global rights of Sylvant (siltuximab), a rare blood disorder drug, from Janssen Sciences Ireland UC for $115m.
Production & Manufacturing > Manufacturing > News
Eureka Therapeutics announces Boehringer Ingelheim is exercising option to license novel TCRm) antibodies
Eureka Therapeutics announced that Boehringer Ingelheim has elected to exercise an option for the exclusive license of novel human TCR-mimicking (TCRm) antibodies against an undisclosed target to be used for the potential development and commercialization of therapies for cancer patients.
Drug Research > Drug Discovery & Development > News
Clinigen acquires global rights to Proleukin outside US
Clinigen Group has acquired the global rights to Proleukin (aldesleukin, recombinant interleukin-2) outside the United States from Novartis.
Production & Manufacturing > Manufacturing > News
Roche’s baloxavir marboxil succeeds in phase III flu study
By PBR Staff Writer
A phase III CAPSTONE-2 study has demonstrated that baloxavir marboxil reduced symptoms in people at high risk of complications from the flu.
Contract Research & Services > Clinical Trials > News
Ironwood Pharmaceuticals starts Phase IIIb study of linaclotide in adult patients with IBS-C
Ironwood Pharmaceuticals has started a phase IIIb clinical trial evaluating the efficacy and safety of linaclotide 290 mcg on multiple abdominal symptoms in addition to pain, including bloating and discomfort, in adult patients with irritable bowel syndrome with constipation (IBS-C).
Contract Research & Services > Clinical Trials > News

PBR Supplier Recommendations

CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.... Contract Research & Services > Clinical Trials > Suppliers
Persistence Market Research: Next-Gen Industry Insights & Growth Outlook
Persistence Market Research (PMR) is essentially a third-party research firm. Our model of research is a remarkable coordinated effort of information investigation and market look into procedure to enable organizations to accomplish ideal execution. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes. ... Suppliers
Future Market Insights: Global Industry Outlook & Business Review
FMI, catering to clients in more than 150 different countries, is a top-ranking provider of market intelligence and research. We are headquartered in the global financial capital, London and boast of some of the finest delivery centers in the U.S. and India. Our research and consulting experts have helped a multitude of businesses to manage their individual challenges in an aggressively evolving marketplace with great precision and boldness.... Suppliers
Transparency Market Research: In-depth Analysis, Accurate Results
Transparency Market Research (TMR) is a pioneer enterprise in the field of market research. We provide a plethora of services ranging from customized research, syndicated research, and consultation services. TMR’s worldwide and regional insights on the market cover industries such as chemicals, pharmaceuticals, media and technology, consumer goods, food and beverages, among others. Every deeply researched report from TMR offers its clients a panoramic vision of the market, its prognosis and statistical forecasts, a detailed segmentation, key ongoing trends, vendor landscape along with strategic recommendations.... Suppliers
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Delivery > Suppliers
See more

PBR White Paper Recommendations

Malvern: Understanding and minimizing polycaprolactone degradation during processing using multi-detector GPC and rheology By Malvern Panalytical
Measuring degradation related changes in molecular weight and rheology during polycaprolactone processing... White Papers How Malvern Panalytical helped GSK India optimize their manufacturing process using By Malvern Panalytical
GSK India is headquartered at Worli, Mumbai with the manufacturing unit being located at Nashik. A second manufacturing facility at Vemgal, Karnataka is due to be completed in 2018.... White Papers Malvern: High sensitivity gel permeation chromatography for agrochemical analysis By Malvern Panalytical
Exploring why Syngenta opted for an OMNISEC system... White Papers Malvern: Measuring the rheology of thermoplastic polymer melts By Malvern Panalytical
Using rotational and capillary rheometry to characterize polymer melts... White Papers Malvern: Optimizing metal powders for additive manufacturing By Malvern Panalytical
Exploring the impact of particle morphology and powder flowability.... White Papers See more
1-15 of 56655 results